Cargando…
Inhibition of acid ceramidase elicits mitochondrial dysfunction and oxidative stress in pancreatic cancer cells
Although the inhibition of acid ceramidase (AC) is known to induce antitumor effects in various cancers, there are few reports in pancreatic cancer, and the underlying mechanisms remain unclear. Moreover, there is currently no safe administration method of AC inhibitor. Here the effects of gene ther...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586682/ https://www.ncbi.nlm.nih.gov/pubmed/34459070 http://dx.doi.org/10.1111/cas.15123 |
_version_ | 1784597941997010944 |
---|---|
author | Taniai, Tomohiko Shirai, Yoshihiro Shimada, Yohta Hamura, Ryoga Yanagaki, Mitsuru Takada, Naoki Horiuchi, Takashi Haruki, Koichiro Furukawa, Kenei Uwagawa, Tadashi Tsuboi, Kazuhito Okamoto, Yasuo Shimada, Shu Tanaka, Shinji Ohashi, Toya Ikegami, Toru |
author_facet | Taniai, Tomohiko Shirai, Yoshihiro Shimada, Yohta Hamura, Ryoga Yanagaki, Mitsuru Takada, Naoki Horiuchi, Takashi Haruki, Koichiro Furukawa, Kenei Uwagawa, Tadashi Tsuboi, Kazuhito Okamoto, Yasuo Shimada, Shu Tanaka, Shinji Ohashi, Toya Ikegami, Toru |
author_sort | Taniai, Tomohiko |
collection | PubMed |
description | Although the inhibition of acid ceramidase (AC) is known to induce antitumor effects in various cancers, there are few reports in pancreatic cancer, and the underlying mechanisms remain unclear. Moreover, there is currently no safe administration method of AC inhibitor. Here the effects of gene therapy using siRNA and shRNA for AC inhibition with its mechanisms for pancreatic cancer were investigated. The inhibition of AC by siRNA and shRNA using an adeno‐associated virus 8 (AAV8) vector had antiproliferative effects by inducing apoptosis in pancreatic cancer cells and xenograft mouse model. Acid ceramidase inhibition elicits mitochondrial dysfunction, reactive oxygen species accumulation, and manganese superoxide dismutase suppression, resulting in apoptosis of pancreatic cancer cells accompanied by ceramide accumulation. These results elucidated the mechanisms underlying the antitumor effect of AC inhibition in pancreatic cancer cells and suggest the potential of the AAV8 vector to inhibit AC as a therapeutic strategy. |
format | Online Article Text |
id | pubmed-8586682 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85866822021-11-18 Inhibition of acid ceramidase elicits mitochondrial dysfunction and oxidative stress in pancreatic cancer cells Taniai, Tomohiko Shirai, Yoshihiro Shimada, Yohta Hamura, Ryoga Yanagaki, Mitsuru Takada, Naoki Horiuchi, Takashi Haruki, Koichiro Furukawa, Kenei Uwagawa, Tadashi Tsuboi, Kazuhito Okamoto, Yasuo Shimada, Shu Tanaka, Shinji Ohashi, Toya Ikegami, Toru Cancer Sci Original Articles Although the inhibition of acid ceramidase (AC) is known to induce antitumor effects in various cancers, there are few reports in pancreatic cancer, and the underlying mechanisms remain unclear. Moreover, there is currently no safe administration method of AC inhibitor. Here the effects of gene therapy using siRNA and shRNA for AC inhibition with its mechanisms for pancreatic cancer were investigated. The inhibition of AC by siRNA and shRNA using an adeno‐associated virus 8 (AAV8) vector had antiproliferative effects by inducing apoptosis in pancreatic cancer cells and xenograft mouse model. Acid ceramidase inhibition elicits mitochondrial dysfunction, reactive oxygen species accumulation, and manganese superoxide dismutase suppression, resulting in apoptosis of pancreatic cancer cells accompanied by ceramide accumulation. These results elucidated the mechanisms underlying the antitumor effect of AC inhibition in pancreatic cancer cells and suggest the potential of the AAV8 vector to inhibit AC as a therapeutic strategy. John Wiley and Sons Inc. 2021-09-13 2021-11 /pmc/articles/PMC8586682/ /pubmed/34459070 http://dx.doi.org/10.1111/cas.15123 Text en © 2021 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Taniai, Tomohiko Shirai, Yoshihiro Shimada, Yohta Hamura, Ryoga Yanagaki, Mitsuru Takada, Naoki Horiuchi, Takashi Haruki, Koichiro Furukawa, Kenei Uwagawa, Tadashi Tsuboi, Kazuhito Okamoto, Yasuo Shimada, Shu Tanaka, Shinji Ohashi, Toya Ikegami, Toru Inhibition of acid ceramidase elicits mitochondrial dysfunction and oxidative stress in pancreatic cancer cells |
title | Inhibition of acid ceramidase elicits mitochondrial dysfunction and oxidative stress in pancreatic cancer cells |
title_full | Inhibition of acid ceramidase elicits mitochondrial dysfunction and oxidative stress in pancreatic cancer cells |
title_fullStr | Inhibition of acid ceramidase elicits mitochondrial dysfunction and oxidative stress in pancreatic cancer cells |
title_full_unstemmed | Inhibition of acid ceramidase elicits mitochondrial dysfunction and oxidative stress in pancreatic cancer cells |
title_short | Inhibition of acid ceramidase elicits mitochondrial dysfunction and oxidative stress in pancreatic cancer cells |
title_sort | inhibition of acid ceramidase elicits mitochondrial dysfunction and oxidative stress in pancreatic cancer cells |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586682/ https://www.ncbi.nlm.nih.gov/pubmed/34459070 http://dx.doi.org/10.1111/cas.15123 |
work_keys_str_mv | AT taniaitomohiko inhibitionofacidceramidaseelicitsmitochondrialdysfunctionandoxidativestressinpancreaticcancercells AT shiraiyoshihiro inhibitionofacidceramidaseelicitsmitochondrialdysfunctionandoxidativestressinpancreaticcancercells AT shimadayohta inhibitionofacidceramidaseelicitsmitochondrialdysfunctionandoxidativestressinpancreaticcancercells AT hamuraryoga inhibitionofacidceramidaseelicitsmitochondrialdysfunctionandoxidativestressinpancreaticcancercells AT yanagakimitsuru inhibitionofacidceramidaseelicitsmitochondrialdysfunctionandoxidativestressinpancreaticcancercells AT takadanaoki inhibitionofacidceramidaseelicitsmitochondrialdysfunctionandoxidativestressinpancreaticcancercells AT horiuchitakashi inhibitionofacidceramidaseelicitsmitochondrialdysfunctionandoxidativestressinpancreaticcancercells AT harukikoichiro inhibitionofacidceramidaseelicitsmitochondrialdysfunctionandoxidativestressinpancreaticcancercells AT furukawakenei inhibitionofacidceramidaseelicitsmitochondrialdysfunctionandoxidativestressinpancreaticcancercells AT uwagawatadashi inhibitionofacidceramidaseelicitsmitochondrialdysfunctionandoxidativestressinpancreaticcancercells AT tsuboikazuhito inhibitionofacidceramidaseelicitsmitochondrialdysfunctionandoxidativestressinpancreaticcancercells AT okamotoyasuo inhibitionofacidceramidaseelicitsmitochondrialdysfunctionandoxidativestressinpancreaticcancercells AT shimadashu inhibitionofacidceramidaseelicitsmitochondrialdysfunctionandoxidativestressinpancreaticcancercells AT tanakashinji inhibitionofacidceramidaseelicitsmitochondrialdysfunctionandoxidativestressinpancreaticcancercells AT ohashitoya inhibitionofacidceramidaseelicitsmitochondrialdysfunctionandoxidativestressinpancreaticcancercells AT ikegamitoru inhibitionofacidceramidaseelicitsmitochondrialdysfunctionandoxidativestressinpancreaticcancercells |